Skip to main content
Premium Trial:

Request an Annual Quote

UMMS Will Help BioMachines Create Proteomics Division

NEW YORK (GenomeWeb News) - BioMachines and the University of Massachusetts Medical School announced a partnership to create a new proteomic division at the company, BioMachines said today.
 
The new division will be named Applied Proteomics Services. According to BioMachines CEO Tom Larrichio, the company will provide protein analysis through a fee-for-service model.
 
Sunny Tam and Douglas Hinerfeld, researchers from the medical school's Proteomic Fractionation Group, will support the new division.
 
Under the agreement, the group will provide diverse proteomic sample preparation, fractionation, and mass spectrometry services for analysis.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.